CARDERO RESOURCE

F:CR5 Germany Biotechnology
Market Cap
$1.36 Billion
€1.33 Billion EUR
Market Cap Rank
#7563 Global
#808 in Germany
Share Price
€23.00
Change (1 day)
+3.60%
52-Week Range
€11.00 - €25.90
All Time High
€25.90
About

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b cli… Read more

CARDERO RESOURCE (CR5) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -0.103x

Based on the latest financial reports, CARDERO RESOURCE (CR5) has a cash flow conversion efficiency ratio of -0.103x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-13.42 Million) by net assets (€130.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

CARDERO RESOURCE - Cash Flow Conversion Efficiency Trend (2020–2024)

This chart illustrates how CARDERO RESOURCE's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

CARDERO RESOURCE Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CARDERO RESOURCE ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for CARDERO RESOURCE (2020–2024)

The table below shows the annual cash flow conversion efficiency of CARDERO RESOURCE from 2020 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €73.38 Million €-47.50 Million -0.647x -12.67%
2023-12-31 €93.73 Million €-53.84 Million -0.574x -324.51%
2022-12-31 €-97.99 Million €-25.07 Million 0.256x +12.82%
2021-12-31 €-60.95 Million €-13.82 Million 0.227x -17.69%
2020-12-31 €-43.65 Million €-12.03 Million 0.276x --